The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy (Q40115119)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224401%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224401%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

1 reference

1 reference

E. Kedar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224401

1 September 2023

D. W. Weiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224401

1 September 2023

language of work or name

1 reference

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224401%20AND%20SRC:MED&resulttype=core&format=json

Advances in Cancer Research

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224401%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224401%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

171-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224401%20AND%20SRC:MED&resulttype=core&format=json

An Analysis of Effector T Cell Generation and Function in Mice Exposed to Influenza A or Sendai Viruses

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Secondary induction of cytotoxic T lymphocytes with solubilized syngeneic tumor cell plasma membranes

1 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Rauscher leukemia virus-induced tumor antigens: Complete separation from gp70, p30 and H-2

1 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigen-specific suppression of cytotoxic T cell responses in mice. I. Suppressor T cells are not cytotoxic cells

1 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Surface markers on the T cells that regulate cytotoxic T-cell responses I. The Ly phenotype of suppressor T cells changes as a function of time, and is distinct from that of helper or cytotoxic T cells

1 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens

1 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

10

27

2521

Alexander

1967

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-free media of mixed lymphocyte cultures augmenting sensitizationin vitro of mouse T lymphocytes against allogeneic fibroblasts

1 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The Induction of Autoreactive T Lymphocytes by Allogeneic Effect Factor (AEF): Relevance to Normal Pathways of Lymphocyte Differentiation

1 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Removal of PHA from supernatants containing T-cell growth factor

1 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Surface Antigens on Transplantable Tumor Cell Lines Producing Mouse Type C Viruses

1 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes

1 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigen-specific stimulation and trans-stimulation of T cells in long-term culture

1 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The major histocompatibility complex--genetics and biology. (First of three parts).

1 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Differential function of major histocompatibility complex antigens in T-lymphocyte activation

1 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity

1 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cloned Cytotoxic and Non-Cytotoxic Lymphocytes in Mouse and Man: Their Reactivities and a Large Cell Surface Membrane Protein (LMP) Differentiation Marker System

1 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Monoclonal cytolytic T-cell lines

1 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunobiology of rat neoplasia

1 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Induction of Tumor-Immune Responses and Their Interaction with the Developing Tumor

1 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell mediated cytotoxicity against HLA-D region products expressed in monocytes and B lymphocytes. III. Inhibition by monoclonal antibodies and study of an HLA-B/DR recombinant

1 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Interferon production in cocultures between mouse spleen cells and tumor cells. Possible role of mycoplasmas in interferon induction

1 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Role of MHC gene products in immune regulation

1 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilli

1 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

Controversy about MIRVs

52

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Potentiation of the in vitro specific cytotoxic response to syngeneic lymphoma cells by PPD-stimulated tuberculin sensitive cells

1 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens

1 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The effect of 2-mercaptoethanol on murine mixed lymphocyte cultures

1 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A dual recognition model for cytotoxic T cells based on thymic selection of precursors with low affinity for Self H-2 antigens

1 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity

1 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Mitogenic effects of partially purified interleukin 2 on thymocyte subpopulations and spleen t cells of the mouse

1 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Induction of natural killer cell activity and allocytotoxicity in human peripheral blood lymphocytes after mixed lymphocyte culture

1 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Phytohaemagglutinin-induced susceptibility to lysis by natural and activated killer cells of autologous allogeneic and xenogeneic target cells

1 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes

1 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Expression of alien histocompatibility antigens on SJL/J tumors detected by cell-mediated and serological analyses

1 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Direct estimation of frequency of cytotoxic T lymphocytes by a modified plaque assay

1 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition

1 September 2023

73

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Continued growth of functional human T lymphocytes: production of human T-cell growth factor

1 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

76

31

1140

Boranic

1970

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors

1 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Induction of tumor immunity by intratumoral chemotherapy

1 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Graft versus leukemia: quantification of adoptive immunotherapy in murine leukemia

1 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

1 September 2023

82

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes

1 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies

1 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes

1 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Differential effects of glucocorticosteroids on the functions of helper and suppressor T lymphocytes

1 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunogenic and immunosuppressive components in soluble preparations from moloney murine leukemia virus-induced tumor cells

1 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Suppressor Cells in Neoplastic Disease

1 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity

1 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Studies on the microcytotoxicity test. III. Comparison of [75Se]selenomethionine with [3H]proline, Na2, 51CrO4 and [125I]iododeoxyuridine for pre-labelling target cells in long-term cytotoxicity tests

1 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumour cells in metastatic deposits with altered sensitivity to natural killer cells

1 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Studies on a gross‐virus‐induced lymphoma in the rat. III. Optimisation, specificity and applications of the in vitro immune response

1 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors

1 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens

1 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Helper factor(s) augment in vitro induction of tumor-specific immunity

1 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cell responses to alloantigens. II. In vitro induction of specific Ts by heat-inactivated allogeneic lymphoid cells

1 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes

1 September 2023

108

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In Vitro Induction and Expression of T-Cell Immunity to Tumor-Associated Antigens

1 September 2023

110

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Nonspecific cytotoxic effects of antigen-transformed lymphocytes. III. Relationship to specific cytotoxicity

1 September 2023

112

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The origin of human cancers

1 September 2023

113

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells

1 September 2023

116

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Regulation of the Immune Response by T-Cell Subclasses

1 September 2023

117

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures

1 September 2023

121

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Thein vitro cellular response of human lymphocytes totrinitrophenylated autologous cells: HLA-D restrictionof proliferation but apparent absence of HLArestriction of cytolysis

1 September 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Relationship of tumor-specific transplantation antigens to the histocompatibility complex: Dissociation ofin vitro alloantigen expression andin vivo alloimmunity from tumor-specific transplantation antigen strength

1 September 2023

124

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Local tumor immunotherapy with in vitro activated autochithonous lymphocytes

1 September 2023

126

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

132

41

2658

Cheever

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 September 2023

133

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

134

35

634

Chester

1975

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of tumor-specific immunity VI: Analysis of specificity of immune response by cellular competitive inhibition: Limitations and advantages of the technique

1 September 2023

135

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunogenicity of oncofetal antigens: A review

1 September 2023

136

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell Membrane Antigens Recognized by Anti-Viral and Anti-Trinitrophenyl Cytotoxic T Lymphocytes

1 September 2023

137

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Progressive Loss of H-2 Antigens With Concomitant Increase of Cell-Surface Antigen(s) Determined by Moloney Leukemia Virus in Cultured Murine Lymphomas23

1 September 2023

139

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Autoreactive natural killer-like cells from agar-cloned murine bone marrow cells

1 September 2023

141

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Effect of BUdR on proliferation and development of cytotoxicity in mixed leukocyte culture

1 September 2023

142

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Water-soluble P-815 mastocytoma membrane antigens: separation of tumour-associated antigens from histocompatibility antigens

1 September 2023

144

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immune responses in vitro. I. Culture conditions for antibody synthesis

1 September 2023

145

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Autosensitization in vitro

1 September 2023

147

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Rejection of tumor allografts by mouse spleen cells sensitized in vitro

1 September 2023

148

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Generation of cytotoxic cells in absence of blastogenesis by mouse leukemic cells in mixed cultures

1 September 2023

150

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Colony formation of cytolytic T cells in semisolid medium

1 September 2023

151

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

156

40

3218

Csako

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Reduced humoral and cellular cytotoxic sensitivity in histocompatibility variants of the YAC (Moloney) lymphoma.

1 September 2023

157

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The major histocompatibility complex in man

1 September 2023

158

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastatic capacity

1 September 2023

160

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular requirements for the induction of cytotoxic T cells in vitro

1 September 2023

161

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties

1 September 2023

163

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

H-2 restriction for lymphocyte homing into lymph nodes

1 September 2023

165

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro activation of cellular immune response to Gross virus-induced lymphoma

1 September 2023

166

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse

1 September 2023

167

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTES

1 September 2023

168

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Molecular heterogeneity of H-2 antigens

1 September 2023

170

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

H-2-restricted T-cell-mediated cytotoxicity: rediscovering allo-H-2-reactivity?

1 September 2023

172

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cloned lines of natural killer cells

1 September 2023

173

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cells may express multiple activities: specific allohelp, cytolysis, and delayed-type hypersensitivity are expressed by a cloned T-cell line

1 September 2023

174

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers

1 September 2023

175

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immune response to weakly immunogenic virally induced tumors. IV. Dissociated recognition of H-2 and tumor-associated antigens

1 September 2023

177

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immune responses to weakly immunogenic virally induced tumors. V. Short in vitro cultivation of YAC changes its antigenic properties

1 September 2023

178

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Autologous bone marrow transplantation in patients with adult acute leukemia in relapse

1 September 2023

180

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Susceptibility of adherent versus suspension target cells derived from adherent tissue culture lines to cell-mediated cytotoxicity in rapid 51Cr-release assays

1 September 2023

188

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro reactivity of human lymphocytes after cryopreservation using a programmed cooling device

1 September 2023

189

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Eradication of tumour cells by successive injections of allogeneic immune and hyperimmune peritoneal cells in a murine lymphoma system

1 September 2023

190

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated anti-tumor response in the RL♂ 1 system I. T nature, H-2 Dd involvement and antigenic specificity of the effector cells

1 September 2023

192

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

1 September 2023

194

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor

1 September 2023

195

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

1 September 2023

196

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma-interferon

1 September 2023

199

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Suppression of the mixed lymphocyte reaction in man by a soluble T-cell factor. Specificity of the factor for both responder and stimulator

1 September 2023

209

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Removal of phytohemagglutinin from conditioned medium by affinity chromatography

1 September 2023

212

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

213

36

3561

Farkas-Himsley

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses

1 September 2023

217

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

218

32

997

Fass

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Clones of alloreactive T cells

1 September 2023

219

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

220

29

2177

Fefer

1969

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

221

33

641

Fefer

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems

1 September 2023

225

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

HLA-D region-associated determinants serve as targets for human cell-mediated lysis

1 September 2023

227

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigens

1 September 2023

229

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Differential cyclophosphamide sensitivity of suppressor and cytotoxic cell precursors

1 September 2023

230

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Characterization of suppressor lymphocytes generated in vitro

1 September 2023

231

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

1 September 2023

233

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Variation in MHC Antigenic Profiles of Tumor Cells and its Biological Effects

1 September 2023

235

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines

1 September 2023

236

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The origin of metastatic heterogeneity in tumors

1 September 2023

237

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Metastasis results from preexisting variant cells within a malignant tumor

1 September 2023

238

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The Biology of Cancer Invasion and Metastasis

1 September 2023

239

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

240

42

496

Fidler

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Induction, control and consequences of virus specific cytotoxic T cells

1 September 2023

241

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Influence of H-2 antigen expression on killer T cell specificity, differentiation, and induction

1 September 2023

243

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.

1 September 2023

245

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Expression of the I-E target antigen for T-cell killing requires two genes

1 September 2023

249

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum

1 September 2023

252

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Differences in Cell Surface Antigens of Tumor Metastases and Those of the Local Tumor2

1 September 2023

253

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Phytohemagglutinin-activated autochthonous lymphocytes for systemic immunotherapy of human neoplasms

1 September 2023

257

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse

1 September 2023

262

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

264

10

105

Gabizon

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immune responses to weakly immunogenic virally induced tumors I. Overcoming low responsiveness by priming mice with a syngeneicin vitro tumor line or allogeneic cross-reactive tumor

1 September 2023

265

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor

1 September 2023

268

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Potentiation of the T-lymphocyte response to mitogens. I. The responding cell

1 September 2023

270

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

271

41

681

Giampietri

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Long term culture of tumour-specific cytotoxic T cells

1 September 2023

272

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Interleukin-2 dependent culture of cytolytic T cell lines

1 September 2023

273

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Long-term culture of human antigen-specific cytotoxic T-cell lines

1 September 2023

274

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Molecular characterization of interleukin 2.

1 September 2023

277

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Destruction of mouse and rat embryo cells in tissue culture by lymph node cells from unsensitized rats

1 September 2023

279

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines

1 September 2023

282

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Murine T lymphocyte clones with distinct immunological functions

1 September 2023

283

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice

1 September 2023

284

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Collaboration between distinct subpopulations of T cells in in vitro generation of effector cells capable of growth prevention of syngeneic SV40-induced sarcoma in mice

1 September 2023

286

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

1 September 2023

287

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Macrophage requirement forin vitro generation of specific, secondary cell-mediated cytotoxicity against SV40-induced tumor-associated antigens in mice

1 September 2023

288

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Indomethacin-sensitive suppressor cells regulate the cell-mediated cytotoxic response to SV 40-induced tumor-associated antigens in mice

1 September 2023

289

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T–T cell collaboration in rejection of a syngeneic SV40-induced sarcoma in mice

1 September 2023

290

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Inhibition of Cell-Mediated Cytotoxicity Against Tumor-Associated Antigens by Suppressor Cells From Tumor-Bearing Mice

1 September 2023

292

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Sensitisation of lymphocytes in vitro against human melanoma-associated antigens.

1 September 2023

295

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular reactions against Burkitt lymphoma cells. 3. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells.

1 September 2023

296

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Exclusive involvement of H-2D(b) or H-2K(d) product in the interaction between T-killer lymphocytes and syngeneic H-2(b) or H-2(d) viral lymphomas

1 September 2023

297

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor

1 September 2023

302

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice

1 September 2023

305

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Radioisotope assay for evaluation of in vivo natural cell‐mediated resistance of mice to local transplantation of tumor cells

1 September 2023

306

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vivo anti-tumor effects of local adoptive transfer of mouse and human cultured lymphoid cells

1 September 2023

307

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients

1 September 2023

308

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

309

36

2119

Gotohda

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Anti-self HLA may be clonally expressed

1 September 2023

310

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Journal of Experimental Medicine

1 September 2023

311

152

182

Goulmy

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity

1 September 2023

312

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

316

40

4428

Greenberg

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 September 2023

318

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The genetic and cellular basis of regulation of the immune response to tumor antigens

1 September 2023

320

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 September 2023

323

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor

1 September 2023

324

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Establishment of continuous cultures of Thy1.2+, Lytl+,2−T cells with purified interleukin 3

1 September 2023

330

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo

1 September 2023

331

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The destruction of lymphoma cells by activated human lymphocytes

1 September 2023

332

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Destruction of Lymphoid Cells by Activated Human Lymphocytes

1 September 2023

333

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Concanavalin A-inducible, interleukin-2-producing T cell hybridoma

1 September 2023

335

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Mixed lymphocyte cultures produce effector cells: model in vitro for allograft rejection

1 September 2023

336

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated immunity to mouse tumors: some recent findings

1 September 2023

339

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specific sensitization of lymphocytes to tumor antigens by co-cultivation with peritoneal cells exposed to such antigens

1 September 2023

340

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated reactivity to antigens shared by moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas

1 September 2023

341

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Monoclonal Antibodies to Tumor Antigens

1 September 2023

342

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

343

40

2135

Hengst

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antiviral antibodies inhibit the lysis of tumour cells by anti-H–2 sera

1 September 2023

345

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-Mediated Immunity to Tumor Cells

1 September 2023

346

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Natural killer cells: their roles in defenses against disease

1 September 2023

350

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus

1 September 2023

351

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Natural killer cells: characteristics and regulation of activity

1 September 2023

353

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2

1 September 2023

356

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The Choice of Animal Tumors for Experimental Studies of Cancer Therapy

1 September 2023

357

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

1 September 2023

358

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Activation of Human Suppressor Cells in Mixed Lymphocyte Cultures

1 September 2023

361

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell mediated lympholysis: CML. A microplate technique requiring few target cells and employing a new method of supernatant collection

1 September 2023

362

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specific cytotoxicity of H-2-incompatible mouse lymphocytes following mixed culture in vitro

1 September 2023

364

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cytotoxicity against tumour-associated antigens not H–2 restricted

1 September 2023

366

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Blocking effect of lyt-2 antibodies on T cell functions

1 September 2023

367

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Solubilization of complexes between tumor-associated and H-2 antigens from a tumor cell plasma membrane

1 September 2023

368

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell interactions in adoptive immune rejection of a syngeneic tumor

1 September 2023

369

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunotherapy for the Patient with Cancer

1 September 2023

370

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specificity of T-cell cones illustrates altered self hypothesis

1 September 2023

371

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis

1 September 2023

372

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth

1 September 2023

374

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro.

1 September 2023

375

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcoma

1 September 2023

376

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The stromal reaction of tumors: an expression of immune surveillance

1 September 2023

377

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains

1 September 2023

380

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Increase in immunogenicity of a pulmonary squamous-cell carcinoma, propagatedin vitro

1 September 2023

382

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

383

39

2466

Jamasbi

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T-cell populations with different functions

1 September 2023

384

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity

1 September 2023

385

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Generation of cytotoxic T lymphocytes by the H-2-encoded E molecules

1 September 2023

386

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunosuppression and the Role of Suppressive Factors in Cancer

1 September 2023

389

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition

1 September 2023

391

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines

1 September 2023

394

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of cell-mediated immunity to murine leukemia cells. IV. Amplification of the generation of cytotoxic lymphocytes by enzymatically and chemically modified stimulator leukemic cells

1 September 2023

397

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Further characterization of suppressor lymphocytes induced by fetal calf serum in murine lymphoid cell cultures: Comparison with in vitro-generated cytotoxic lymphocytes

1 September 2023

398

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes

1 September 2023

399

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of cell-mediated immunity to murine leukemia cells. II. Cytotoxic activity in vitro and tumor-neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures

1 September 2023

400

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia

1 September 2023

401

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of cell-mediated immunity to murine leukemia cells. VII. Methods for augmenting the induction and expression of cytotoxic response in vitro to syngeneic tumors

1 September 2023

405

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of cytotoxic effector cells against human neoplasms. I. Sensitization conditions and effect of cryopreservation on the induction and expression of cytotoxic responses to allogeneic leukemia cells

1 September 2023

406

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells

1 September 2023

411

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Expression of H-2b alloantigens in a variant of a moloney virus-induced YAC (H-2a) lymphoma

1 September 2023

413

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

415

35

346

Kende

1975

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Natural Killer Cells in the Mouse: An Alternative Immune Surveillance Mechanism?

1 September 2023

418

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

An Analysis of the Murine NK Cell as to Structure, Function and Biological Relevance

1 September 2023

419

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

cell surface glycoproteins of murine cytotoxic T lymphocytes. I. T 145, a new cell surface glycoprotein selectively expressed on Ly 1-2(+) cytotoxic T lymphocytes

1 September 2023

421

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Suppressor cells of immune reactivity in malignancy

1 September 2023

422

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Production of interferon in the murine mixed lymphocyte culture. II. Interferon production is a T cell-dependent function, independent of proliferation

1 September 2023

423

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. I. screening of immunogenic components by isopycnic ultracentrifugation and polyacrylamide electrophoresis of a tumor homogenate

1 September 2023

424

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

428

20

452

Klein

1960

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma

1 September 2023

431

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The role of gene dosage and genetic transpositions in carcinogenesis

1 September 2023

432

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution

1 September 2023

433

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids

1 September 2023

434

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The Major Histocompatibility Complex of the Mouse

1 September 2023

437

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Polymorphism of the mouse H-2 loci

1 September 2023

438

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Serological distinction of mutants B6.CH(zl) and B6.M505 from strain C57BL-6.

1 September 2023

440

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The traditional and a new version of the mouse H-2 complex

1 September 2023

441

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Continuous cultures of fused cells secreting antibody of predefined specificity

1 September 2023

447

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cloning and characterization of primary alloreactive human T-lymphocytes

1 September 2023

448

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes

1 September 2023

450

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

1 September 2023

451

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell mediated lympholysis in man. Occurrence of unexpected, HL-A (LA and FOUR) irrelevant lympholysis

1 September 2023

452

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cloned cytotoxic T lymphocytes: A new, complementary approach to HLA-typing

1 September 2023

453

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Typing by cytotoxic lymphocytes. Genetics of HLA-non-A, B, C determinants - family studies.

1 September 2023

454

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation

1 September 2023

456

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-surface antigens induced by RNA tumour viruses

1 September 2023

460

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line

1 September 2023

461

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Sendai virus-specific, H-2-restricted cytotoxic T lymphocyte responses of nude mice grafted with allogeneic or semi-allogeneic thymus glands

1 September 2023

462

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation

1 September 2023

463

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cyclosporin a permits the distinction between specific T and NK activity generated in a human MLC

1 September 2023

464

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Two distinct factors are required for induction of T-cell growth

1 September 2023

467

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice

1 September 2023

469

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views

1 September 2023

474

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man

1 September 2023

475

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia

1 September 2023

476

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Xenogeneic serum-induced murine cytotoxic cells. I. The generation of effector components specific for self and allogeneic target cells

1 September 2023

480

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens

1 September 2023

481

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

1 September 2023

482

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Properties of RBL-5 leukemia cells cultivated in vitro

1 September 2023

483

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

487

41

4420

Lotze

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection

1 September 2023

488

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection

1 September 2023

490

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular immune response against tumor cells. I. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells.

1 September 2023

492

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Enumeration of alloreactive helper T lymphocytes which cooperate with cytolytic T lymphocytes

1 September 2023

494

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Restimulation of cytolytic T-lymphocytes in long-term mixed leukocyte cultures. 1. Physical and proliferative characteristics of cytolytic T-lymphocytes restimulated at low cell density

1 September 2023

498

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Generation of cytotoxic T lymphocytes in vitro. IV. Functional activation of memory cells in the absence of DNA synthesis

1 September 2023

499

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Quantitation and cloning of cytolytic T lymphocytes and their precursors

1 September 2023

500

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

HLA restriction of cell-mediated lysis of influenza virus-infected human cells

1 September 2023

502

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Intralymphatic therapy with immune lymphocytes

1 September 2023

503

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Clones of Human Cytotoxic T Lymphocytes Derived from an Allosensitized Individual: HLA Specificity and Cell Surface Markers

1 September 2023

506

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

Cancer Treatment Reports

507

61

1459

Marks

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

H-2a-associated alloantigen expressed by several transplacentally-induced lung tumours of C3Hf mice

1 September 2023

509

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro "education" on autologous human sarcoma generates non-specific killer cells

1 September 2023

510

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Mechanism of Specific Tumor-Cell Lysis by Alloimmune T Lymphocytes: Resolution and Characterization of Discrete Steps in the Cellular Interaction

1 September 2023

511

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T Cells Scrutinized at Rüdesheim Meeting

1 September 2023

512

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumors; a mixed bag of cells

1 September 2023

513

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Protection against murine ascites tumours by lymphoid cell populations with T memory or cytotoxicity

1 September 2023

519

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A one-receptor view of T-cell behaviour

1 September 2023

520

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

521

42

150

Mazauric

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

523

42

913

Mazumder

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Fine specificity of cytotoxic T lymphocytes directed against H-2Ld

1 September 2023

527

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes

1 September 2023

528

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media

1 September 2023

529

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

531

29

848

Mihich

1969

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Quantitative studies of the activation of cytotoxic lymphocyte precursor cells

1 September 2023

533

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Identification of the murine leukemia viral antigens detected on mouse cells by H-2 alloantisera

1 September 2023

536

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

On the heterogeneity of murine natural killer cells

1 September 2023

537

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

538

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Interleukin 1 and T cell activation

1 September 2023

540

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Biochemical separation of interleukin 2

1 September 2023

541

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

544

39

785

Mokyr

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity

1 September 2023

545

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

546

42

974

Mokyr

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A Modification of the Mycoplasma Serum-Drop Growth Inhibition Test

1 September 2023

547

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cancer Immunity—Hypothesis and Clinical Trial of Lymphocytotherapy for Malignant Diseases

1 September 2023

551

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro studies on cell-mediated cytotoxicity by means of a terminal labeling technique

1 September 2023

553

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Surface markers of cloned human T cells with various cytolytic activities

1 September 2023

555

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 September 2023

556

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivatedin vitro

1 September 2023

557

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Production of T-cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report

1 September 2023

559

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Multiple activities of a cloned cell line mediating natural killer cell function

1 September 2023

560

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Established Murine Cytolytic T-Cell Lines as Tools for a Somatic Cell Genetic Analysis of T-Cell Functions

1 September 2023

561

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunotherapy of Malignant Disease

1 September 2023

563

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Macrophage or T cell - that is the question

1 September 2023

565

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Ia antigens as restriction molecules in Ir-gene controlled T-cell proliferation

1 September 2023

566

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera

1 September 2023

568

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Suppressor Cells: Permitters and Promoters of Malignancy?

1 September 2023

569

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Absolute requirement for adherent cells in the production of human interleukin 2 (IL2)

1 September 2023

571

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

574

38

4105

Nicolson

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 September 2023

575

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules

1 September 2023

579

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

580

41

361

Old

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Interleukin 1 is more than an interleukin

1 September 2023

582

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Autoimmune encephalomyelitis: activation of thymus lymphocytes against syngeneic brain antigens in vitro

1 September 2023

583

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

584

37

1719

Orsini

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration

1 September 2023

589

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

Lymphokines on the move

591

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular origins and targets of costimulator (IL2).

1 September 2023

592

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins

1 September 2023

593

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cell growth factor abrogates concanavalin A-induced suppressor cell function

1 September 2023

594

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcoma

1 September 2023

598

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Mouse Cell-Mediated Lympholysis Assay in Serum-Free and Mouse Serum-Supplemented Media: Culture Conditions and Genetic Factors

1 September 2023

601

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Environmental and Genetic Control of T Cell Activation In Vitro: A Study Using Isolated Alloantigen-Activated T Cell Clones

1 September 2023

603

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Herpes-simplex-virus-specific, H-2Dk-restricted T lymphocytes bear receptors for H-2Dd alloantigen

1 September 2023

610

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Primary and secondaryin vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system

1 September 2023

613

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity ofin vitro generated secondary CTL with syngeneic tumor cells

1 September 2023

614

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes

1 September 2023

615

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Soluble factors substitute for T–T-cell collaboration in generation of T-killer lymphocytes

1 September 2023

616

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.

1 September 2023

617

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Are tumor-associated transplantation antigens of chemically induced sarcomas related to alien histocompatibility antigens?

1 September 2023

618

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Dissociation ofH-2 recognition by antibody and cytotoxic T cells of a cloned murine leukemia cell line

1 September 2023

620

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunostimulation of the Lymphodependent Phase of Neoplastic Growth

1 September 2023

623

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

626

40

4565

Przepiorka

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Adoptive immunochemotherapy of a transplantable AKR leukemia (K36)

1 September 2023

627

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

Cancer Treatment Reports

629

62

1085

Ramseur

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

631

42

457

Raso

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A differentiation factor required for the expression of cytotoxic T-cell function

1 September 2023

632

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes

1 September 2023

636

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

1 September 2023

638

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Development and characterization of allospecific long-term human cytolytic T-cell lines

1 September 2023

639

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes

1 September 2023

641

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Heterogeneity of human T-cell growth factor(s) due to variable glycosylation.

1 September 2023

642

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cell growth factor receptors. Quantitation, specificity, and biological relevance

1 September 2023

643

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumour-derived lymphoid cells prevent tumour growth in Winn assays

1 September 2023

644

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Differences in the expression of histocompatibility antigens on mouse lymphocytes and tumor cells: immunochemical studies

1 September 2023

645

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Regulation of the mixed leukocyte culture reaction by suppressor cells

1 September 2023

646

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Target-effector interaction in the natural killer cell system: isolation of target structures

1 September 2023

647

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor

1 September 2023

649

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo

1 September 2023

652

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

1 September 2023

654

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Culture-generated suppressor cells: evidence for an adherent cell component

1 September 2023

655

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Passive Immunotherapy of Cancer in Animals and Man

1 September 2023

656

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro growth of murine T cells. III. Method for separation of T cell growth factor (TCGF) from concanavalin A and biological activity of the resulting TCGF

1 September 2023

660

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro growth of murine T cells. IV. Use of T-cell growth factor to clone lymphoid cells

1 September 2023

661

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The in vivo activity of in vitro immunized mouse thymocytes. 3. Fate of in vitro immunized thymocytes

1 September 2023

665

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response

1 September 2023

667

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Enhancement of the primary cytotoxic response to membrane by a lymphokine costimulator

1 September 2023

668

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Loss of reactivity of a BALB/c myeloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes

1 September 2023

671

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulationin vitro

1 September 2023

678

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell surface polypeptides of murine T-cell clones expressing cytolytic or amplifier activity

1 September 2023

680

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Journal of Experimental Medicine

1 September 2023

681

152

270

Sasportes

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT

1 September 2023

682

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Fine specificity and cytolytic activity of continuously growing alloreactive cytotoxic T lymphocyte clones

1 September 2023

683

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specific cytotoxicity in vitro of lymphocytes sensitized in culture against tumor cells

1 September 2023

686

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Genetic specificity of primary and secondary proliferative and cytotoxic responses of human lymphocytes grown in continued culture.

1 September 2023

688

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Is the presence of serologically defined target cell antigens sufficient for binding of cytotoxic T lymphocytes?

1 September 2023

689

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

1 September 2023

691

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Binding of MLR precursors requires immunosorbents which present both self- and alloantigen

1 September 2023

693

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Functional interactions of viral and histocompatibility antigens at tumor cell surfaces

1 September 2023

695

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture

1 September 2023

696

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity.

1 September 2023

697

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumor neutralization by immune in vitro‐sensitized splenocytes depends on an interaction with bone‐marrow‐derived cells

1 September 2023

700

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The dependence of tumor neutralization on bone‐marrow‐derived cells

1 September 2023

701

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Adoptive transfer and specific active immunization of patients with malignant melanoma

1 September 2023

705

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro lymphocyte immunization to cultured human tumor cells: parameters for generation of cytotoxic lymphocytes

1 September 2023

708

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

709

37

4660

Sharma

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

711

7

93

Sharma

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

712

34

115

Sharma

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunization of lymphocytes from cancer patients

1 September 2023

713

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro immunisation against human tumour cells with bacterial extracts

1 September 2023

714

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Effect of a monoclonal anti-lyt-1.1 on the functional activity of precursor, effector, and regulatory cells specific for murine alloantigens

1 September 2023

717

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses

1 September 2023

718

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes

1 September 2023

719

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Significance of the major histocompatibility complex as assessed by T-cell-mediated lympholysis involving syngeneic stimulating cells

1 September 2023

720

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Ly phenotype of cytotoxic T cells for syngeneic tumor

1 September 2023

722

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Mitogen-initiated synthesis and secretion of T cell growth factor(s) by a T-lymphoma cell line

1 September 2023

723

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Some requirements for a linear cell dose response in vitro assay for the T-cell progenitors of cytotoxic lymphocytes

1 September 2023

724

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T lymphocytes with promiscuous cytotoxicity

1 September 2023

726

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

H-2 restriction: independent recognition of H-2 and foreign antigen by a single receptor

1 September 2023

727

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Generation of effector cells from T cell subsets. III. Synergy between Lyt-1 and Lyt-123/23 lymphocytes in the generation of H-2-restricted and alloreactive cytotoxic T cell

1 September 2023

729

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Regulation of the immune response. XI-Cell-mediated feedback of an in vitro cell-mediated immune response

1 September 2023

730

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated cytotoxicity against syngeneic tumors

1 September 2023

731

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Inhibition of an in vitro cell-mediated response: Further experiments on the cell lineage and target of suppressor cells

1 September 2023

732

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts

1 September 2023

734

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Transplantation tolerance across major histocompatibility barriers after total lymphoid irradiation

1 September 2023

735

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor

1 September 2023

739

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T-Cell Growth Factor and the Culture of Cloned Functional T Cells

1 September 2023

741

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T cells, T cells recognition structures, and the major histocompatibility complex

1 September 2023

743

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cytotoxicity: Specificity after in vitro Sensitization

1 September 2023

744

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis

1 September 2023

745

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A simplified method for the production of murine T-cell growth factor free of lectin

1 September 2023

747

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Stimulation of rat lymphocyte proliferation by hydrocortisone during the induction of cell-mediated immunity in vitro

1 September 2023

749

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Studies on the physiological manifestations of cell-mediated cytotoxicity. I. Early metabilic changes in mouse plasmacytoma cells exposed in vitro to sensitized allogeneic splenocytes

1 September 2023

750

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Studies on the physiological manifestations of cell mediated cytotoxicity. II. Inhibition of (3-H)thymidine incorporation by plasmacytoma cells exposed in vitro to sensitized splenocytes

1 September 2023

751

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Allograft Tolerance after Total Lymphoid Irradiation (TLI)

1 September 2023

754

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Susceptibility of anti-H-2-capped target cells to humoral and T lymphocyte-mediated lysis

1 September 2023

756

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

H–2 restriction and non-restriction of T-cell-mediated cytotoxicity against mouse mammary tumour targets

1 September 2023

757

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Natural cytotoxic cells against solid tumors in mice: blocking of cytotoxicity by D-mannose

1 September 2023

758

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cytotoxic cells suppress in vitro generation of cellular immunity by stimulator cell lysis

1 September 2023

762

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects

1 September 2023

763

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Sensitivity of different target cells to the killing action of peripheral lymphocytes stimulated by autologous lymphoblastoid cell lines

1 September 2023

766

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells.

1 September 2023

767

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function

1 September 2023

770

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells

1 September 2023

771

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunologically competent cells in the treatment of malignant disease

1 September 2023

772

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A microassay for cell-mediated immunity

1 September 2023

773

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s)

1 September 2023

774

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells

1 September 2023

775

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of T-lymphocyte-mediated cytotoxicity by infectious murine type C oncornaviruses

1 September 2023

776

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Direct evidence for a two-signal mechanism of cytotoxic T-lymphocyte activation

1 September 2023

780

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Preliminary Observations of the Effects on Breast Adenocarcinoma of Plasma Perfused over Immobilized Protein A

1 September 2023

781

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Bone-marrow transplantation (first of two parts).

1 September 2023

782

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

1 September 2023

786

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance

1 September 2023

790

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Suppression of T cell-mediated immunity by tumor cells: Immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors

1 September 2023

792

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Perspectives in cancer research. Autologous Marrow Support and intensive chemotherapy in cancer patients

1 September 2023

793

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro Induction of Cell-Mediated Immunity Against Tumor Cells by Antigen-Fed Macrophages

1 September 2023

796

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Recruitment of Effector T Lymphocytes Against a Tumor Allograft by T Lymphocytes Sensitized In Vitro2

1 September 2023

797

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens

1 September 2023

804

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation

1 September 2023

805

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis

1 September 2023

809

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Blastogenic factor: its role in the mixed leukocyte culture reaction

1 September 2023

811

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

812

28

2477

Vaage

1968

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

813

4

263

Vaage

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) mice

1 September 2023

814

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin

1 September 2023

815

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

816

37

2680

van Diggelen

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes

1 September 2023

817

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Alloreactive cytotoxicity of interferon-triggered human lymphocytes detected with tumor biopsy targets

1 September 2023

818

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes

1 September 2023

821

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Tumor biopsy cells participating in systems in which cytotoxicity of lymphocytes is generated. Autologous and allogeneic studies

1 September 2023

822

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

1 September 2023

823

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Lyt phenotypes of primary cytotoxic T cells generated across the A and E region of the H-2 complex

1 September 2023

824

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

H-2 restricted cytolytic and noncytolytic T cell clones: isolation, specificity and functional analysis

1 September 2023

825

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site

1 September 2023

827

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2

1 September 2023

828

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours

1 September 2023

829

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cultured human T-cell lines kill autologous solid tumours

1 September 2023

830

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Human tumour—lymphocyte interactionin vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells

1 September 2023

831

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro generation of cytotoxicity against autologous human tumour biopsy cells

1 September 2023

832

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Restricted autologous lymphocytotoxicity in lung neoplasia

1 September 2023

833

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors

1 September 2023

834

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity

1 September 2023

835

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated immune response in vitro. 3. The requirement for macrophages in cytotoxic reactions against cell-bound and subcellular alloantigens

1 September 2023

836

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse

1 September 2023

838

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Secondary cytotoxic allograft responses in vitro. III. The immunogenicity of allogeneic membrane fragments

1 September 2023

839

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice

1 September 2023

840

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors

1 September 2023

841

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The Role of the Major Histocompatibility Gene Complex in Murine Cytotoxic T Cell Responses

1 September 2023

842

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Impact of thymus on the generation of immunocompetence and diversity of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors

1 September 2023

844

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro

1 September 2023

846

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell-mediated immune response of in vitro sensitized lymphocytes to isogeneic methyl-cholanthrene-induced tumor cell lines

1 September 2023

849

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A High Frequency of Cytotoxic Precursor Cells for a Syngeneic Tumour

1 September 2023

850

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

A method for the production and quantitative assay of human lymphokine preparations

1 September 2023

851

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The role of gp70 in the target antigen recognized by murine leukemia virus immune cytotoxic T-lymphocytes

1 September 2023

852

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The Availability for Recognition of Normal H-2 Antigens by Cytotoxic T Lymphocytes on a Rauscher-Virus-transformed Cell, RBL-5A

1 September 2023

853

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Interleukin 2: a class of T cell growth factors

1 September 2023

855

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Mitogen-induced changes in lymphocyte prostaglandin levels: A signal for the induction of suppressor cell activity

1 September 2023

856

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 September 2023

858

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Biochimica et Biophysica Acta

1 September 2023

859

516

301

Weil

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen

1 September 2023

860

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cellular interactions in the generation of cytolytic T lymphocyte responses. Analysis of the helper T cell pathway

1 September 2023

861

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing

1 September 2023

862

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens

1 September 2023

864

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

865

29

2368

Weiss

1969

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunological parameters of the host-parasite relationship in neoplasia

1 September 2023

866

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

MER and Other Mycobacterial Fractions in the Immunotherapy of Cancer

1 September 2023

867

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The autologous mixed-lymphocyte reaction.

1 September 2023

872

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Recognition of polymorphic H-2 domains by T lymphocytes. I. Functional role of different H-2 domains for the generation of alloreactive cytotoxic T lymphocytes and determination of precursor frequencies

1 September 2023

874

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antigen-driven helper cell-independent cloned cytolytic T lymphocytes

1 September 2023

875

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex

1 September 2023

876

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Isotope-Release Cytotoxicity Assay With the Use of Indium-111: Advantage Over Chromium-51 in Long-Term Assays2

1 September 2023

878

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Studies on the regulation of lymphocyte reactivity by normal and activated macrophages

1 September 2023

879

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

INHIBITORY EFFECT OF PRE-IMMUNIZED CBA SPLEEN CELLS ON TRANSPLANTS OF A-STRAIN MOUSE MAMMARY CARCINOMA IN (CBA X A) F1 HYBRID RECIPIENTS.

1 September 2023

882

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS

1 September 2023

883

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

THE EFFECT OF INTRAPERITONEAL INJECTION OF THORACIC DUCT LYMPHOCYTES FROM NORMAL AND IMMUNIZED RATS IN MICE INOCULATED WITH THE LANDSCHUTZ ASCITES TUMOUR.

1 September 2023

884

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

THE EFFECT OF RAT SPLEEN CELLS ON TWO TRANSPLANTED MOUSE TUMOURS.

1 September 2023

885

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cell Mediated Immunity induced in Vitro

1 September 2023

888

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

The requirement of Ia-positive accessory cells for the induction of tumor-specific cytotoxic T lymphocytes in vitro

1 September 2023

889

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Antibody-induced redistribution of normal and tumor associated surface antigens

1 September 2023

890

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis

1 September 2023

891

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

892

8

171

Yefenof

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cancer immunotherapy with HLA-compatible thoracic duct lymphocyte transplantation. A preliminary report.

1 September 2023

895

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Association of Mouse Major Histocompatibility and Rauscher Murine Leukaemia Virus Envelope Glycoprotein Antigens on Leukaemia Cells and their Recognition by Syngeneic Virus-Immune-Cytotoxic T-Lymphocytes

1 September 2023

899

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Continuous culture of T cells cytotoxic for autologous human leukaemia cells

1 September 2023

900

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes.

1 September 2023

901

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection

1 September 2023

902

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells

1 September 2023

903

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells

1 September 2023

904

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

910

36

3842

Zielske

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis

1 September 2023

911

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness

1 September 2023

913

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

Cytotoxic T cells learn specificity for self H–2 during differentiation in the thymus

1 September 2023

914

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60190-6

1 September 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6224401

1 September 2023

1 reference